Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review

References

• Zuppa AF, Barrett JS. Pharmacokinetics and pharmacodynamics in the critically ill child. Pediatr Clin North Am. 2008;55(3):735–755.
   PubMed Web of Science ®Google Scholar
• Varghese JM, Roberts JA, Lipman JL. Pharmacokinetics and pharmacodynamics in critically ill patients. Curr Opin Anaesthesiol. 2010;23(4):472–478.
   PubMed Web of Science ®Google Scholar
• Roberts JA, Abdul-Aziz MH, Lipman J, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Inf Dis. 2014;14(6):498–509.
   PubMed Web of Science ®Google Scholar
• Jaquiss RD, Bronciki RA. An overview of mechanical circulatory support in children. Pediatr Crit Care Med. 2013;14(5 Suppl 1):S3–6.
   PubMed Web of Science ®Google Scholar
• Maslach-Hubbard A, Bratton SL. Extracorporeal membrane oxygenation for pediatric respiratory failure: history, development, and current status. World J Crit Care Med. 20132;4:29–39.
   Google Scholar
• Hayes D Jr, Tobias JD, Kukreja J, et al. Extracorporeal life support for acute respiratory distress syndromes. Ann Thorac Med. 2013;8(3):133–141.
   PubMed Web of Science ®Google Scholar
• Bartlett RH, Gattinoni L. Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol. 2010;76(7):534–540.
   PubMed Web of Science ®Google Scholar
• Dagan O, Klein J, Gruenwald C, et al. Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther Drug Monit. 1993;15(4):263–3.
   PubMed Web of Science ®Google Scholar
• Koren G, Crean P, Klein J, et al. Sequestration of fentanyl by the cardiopulmonary bypass (CPBP). Eur J Clin Pharmacol. 1984;27:51–56.
   PubMed Web of Science ®Google Scholar
• van Saet A, De Wildt SN, Knibbe CA, et al. The effect of adult and pediatric cardiopulmonary bypass on pharmacokinetic and pharmacodynamic parameters. Curr Clin Pharamcol. 2013;8(4):297–318.
   PubMedGoogle Scholar
• Wildschut ED, van Saet A, Pokorna P, et al. The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children. Pediatr Clin N Am. 2012;59:1183–1204.
   PubMed Web of Science ®Google Scholar
• Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet. 2003;42(5):403–417.
   PubMed Web of Science ®Google Scholar
• Shekar K, Fraser JF, Smith MT, et al. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care. 2012;27:741.e9–18.
   PubMed Web of Science ®Google Scholar
• Wildschut ED, Ahsman MJ, Houmes RJ, et al. Pharmacotherapy in neonatal and pediatric extracorporeal membrane oxygenation (ECMO). Curr Drug Metab. 2012;13(6):767–777.
   PubMed Web of Science ®Google Scholar
• Rosen DA, Rosen KR, Silvasi DL. In vitro variability in fentanyl absorption by different membrane oxygenators. J Cardiothorac Anesth. 1990;4(3):332–335.
   PubMedGoogle Scholar
• Mulla H, Lawson G, Von Anrep C, et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion. 2000;15:21–26.
   PubMed Web of Science ®Google Scholar
• Bhatt-Meht V, Annich G. Sedative clearance during extracorporeal membrane oxygenation. Perfusion. 2005;20:309–315.
   PubMed Web of Science ®Google Scholar
• Mehta NM, Halwick DR, Dodson BL, et al. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med. 2007;33(6):1018–1024.
   PubMed Web of Science ®Google Scholar
• Wildschut ED, Ahsman MJ, Allegaert K, et al. Determinants of drug absorption in different ECMO circuits. Intensive Care Med. 2010;36:2109–2116.
   PubMed Web of Science ®Google Scholar
• Preston TJ, Hodge AB, Riley JB, et al. In vitro drug adsorption and plasma free hemoglobin levels associated with hollow fiber oxygenators in the extracorporeal life support (ECLS) circuit. J Extra Corpor Technol. 2007;39:234–237.
   PubMedGoogle Scholar
• Preston TJ, Ratliff TM, Gomez D, et al. Modified surface coatings and their effect on drug absorption within the extracorporeal life support circuit. J Extra Corpor Technol. 2010;42(3):199–202.
   PubMedGoogle Scholar
• Shekar K, Roberts JA, Mcdonald CI, et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care. 2012;16(5):R194.
   PubMed Web of Science ®Google Scholar
• Wagner D, Pasko D, Phillips K, et al. In vitro clearance of dexmedetomidine in extracorporeal membrane oxygenation. Perfusion. 2013;28(1):40–46.
   PubMed Web of Science ®Google Scholar
• Lemaitre F, Hasni N, Leprince P, et al. Propofol, midazolam, vancomycin, and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood. Crit Care. 2015;19:40.
   PubMed Web of Science ®Google Scholar
• Harthan AA, Buckley KW, Heger ML, et al. Medication adsorption into contemporary membrane oxygenator units. J Pediatr Pharmacol Ther. 2014;19(4):288–295.
   PubMedGoogle Scholar
• Gillogly A, Kilbourn C, Waldvogel J, et al. In vitro clearance of intravenous acetaminophen in extracorporeal membrane oxygenation. Perfusion. 2013;28(2):141–145.
   PubMed Web of Science ®Google Scholar
• Shekar K, Roberts JA, Mcdonald CI, et al. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study. Crit Care. 2015;19:164.
   PubMed Web of Science ®Google Scholar
• Shekar K, Roberts JA, Barnett AG, et al. Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models. Crit Care. 2015;19:437.
   PubMed Web of Science ®Google Scholar
• Watt KM, Benjamin DK Jr, Cheifetz IM, et al. Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation. Pediatr Infect Dis J. 2012;31(10):1042–1047.
   PubMed Web of Science ®Google Scholar
• Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. Asaio J. 1999;45(4):250–263.
   PubMed Web of Science ®Google Scholar
• Vet NJ, De Hoog M, Tibboel, et al. The effect of inflammation on drug metabolism: a focus on pediatrics. Drug Discov Today. 2011;16(9–10):250–263.
   Web of Science ®Google Scholar
• Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology – drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157–1167.
   PubMed Web of Science ®Google Scholar
• Bartlett RH. Extracorporeal life support for cardiopulmonary failure. Cur Probl Surg. 1990;27(10):621–705.
   PubMed Web of Science ®Google Scholar
• Carcillo JA, Doughty L, Kofos D, et al. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Med. 2003;29(6):980–984.
   PubMed Web of Science ®Google Scholar
• Alkan-Bozkaya T, Akçevin A, Türkoğlu H, et al. Impact of pulsatile perfusion on clinical outcomes of neonates and infants with complex pathologies undergoing cardiopulmonary bypass procedures. Artif Organs. 2013;37(1):82–86.
   PubMed Web of Science ®Google Scholar
• Talor JJ, Undar A. Pediatric cardiopulmonary bypass: does perfusion mode matter? World J Pediatr Congenit Heart Surg. 2011;2(2):296–300.
   PubMedGoogle Scholar
• O’Neil MP, Fleming JC, Badhwar A, et al. Pulsatile versus nonpulsatile flow during cardiopulmonary bypass: microcirculatory and systemic effects. Ann Thorac Surg. 2012;94(6):2046–2053.
   PubMed Web of Science ®Google Scholar
• Roy BJ, Cornish JD, Clark RH. Venovenous extracorporeal membrane oxygenation affects renal function. Pediatrics. 1995;95(4):573–578.
   PubMed Web of Science ®Google Scholar
• Bhatt-Mehta V, Johnson CE, Schumacher RE. Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy. 1992;12(1):28–32.
   PubMed Web of Science ®Google Scholar
• Shekar K, Roberts JA, Ghassabian S, et al. Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? J Antimicrob Chemother. 2013;68(3):726–727.
   PubMed Web of Science ®Google Scholar
• Vet NJ, Ista E, De Wildt SN, et al. Optimal sedation in pediatric intensive care patients: a systematic review. Intensive Care Med. 2013;39:1524–1534.
   PubMed Web of Science ®Google Scholar
• Curley MAQ, Wypij D, Watson S, et al. Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized control trial. Jama. 2015;313(4):379–389.
   PubMed Web of Science ®Google Scholar
• Verlaat CWM, Heesen GP, Vet NJ, et al. Randomized controlled trial of daily interruption of sedatives in critically ill children. Pediatr Anaesth. 2013;24(2):151–156.
   PubMed Web of Science ®Google Scholar
• DeBerry BB, Lynch JE, Chernin JM, et al. A survey for pain and sedation medications in pediatric patients during extracorporeal membrane oxygenation. Perfusion. 2005;20(3):139–143.
   PubMed Web of Science ®Google Scholar
• Fonsmark L, Rasmussen YH, Carl P. Occurrence of withdrawal in critically ill sedated children. Crit Care Med. 1999;27(1):196–199.
   PubMed Web of Science ®Google Scholar
• Ducharme C, Carnevale FA, Clermont MS, et al. A prospective study of adverse reactions to the weaning of opioids and benzodiazepines among critically ill children. Intensive Crit Care Nurs. 2005;21(3):179–186.
   PubMedGoogle Scholar
• Ista E, van Dijk M, Gamel C, et al. Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation. Crit Care Med. 2008;36(8):2427–2432.
   PubMed Web of Science ®Google Scholar
• Loepke AW. Developmental neurotoxicity of sedatives and anesthetics: a concern for neonatal and pediatric critical care medicine? Pediatr Crit Care Med. 2010;11(2):217–226.
   PubMed Web of Science ®Google Scholar
• Arnold JH, Truog RD, Scavone JM, et al. Changes in pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr. 1991;119(4):639–643.
   PubMed Web of Science ®Google Scholar
• Leuschen MP, Willett LD, Hoie E, et al. Plasma fentanyl levels in infants undergoing extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 1993;105(5):885–891.
   PubMed Web of Science ®Google Scholar
• Dagan O, Klein J, Bohn D, et al. Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med. 1994;22(7):1099–1101.
   PubMed Web of Science ®Google Scholar
• Shekar K, Roberts JA, Mullany DV, et al. Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure. Anaesth Intensive Care. 2012;40:648–655.
   PubMed Web of Science ®Google Scholar
• Hodgson CL, Fan E. A step up for extracorporeal membrane oxygenation: active rehabilitation. Respir Care. 2013;58(8):1388–1389.
   PubMed Web of Science ®Google Scholar
• Arnold JH, Truog RD, Orav EJ, et al. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology. 1990;73:1136–1140.
   PubMed Web of Science ®Google Scholar
• Geiduschek JM, Lynn AM, Bratton SL, et al. Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenation. Crit Care Med. 1997;25(2):360–364.
   PubMed Web of Science ®Google Scholar
• Peters JW, Anderson BJ, Simons SH, et al. Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates. Intensive Care Med. 2005;31(2):257–263.
   PubMed Web of Science ®Google Scholar
• Peters JW, Anderson BJ, Simons SH, et al. Morphine metabolite pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet. 2006;45(7):705–714.
   PubMed Web of Science ®Google Scholar
• Franck LS, Vilardi J, Durand D, et al. Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. Am J Crit Care. 1998;7(5):364–369.
   PubMedGoogle Scholar
• Ahsman MJ, Hanekamp M, Wildschut ED, et al. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet. 2010;49(6):407–419.
   PubMed Web of Science ®Google Scholar
• Mulla H, McCormack P, Lawson G, et al. Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation. Anesthesiology. 2003 Aug;99(2):275–282.
   PubMed Web of Science ®Google Scholar
• Hammaren E, Rosenberg PH, Hynynen M. Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro. Br J Anaesth. 1999;82(1):38–40.
   PubMed Web of Science ®Google Scholar
• Diedrich DA, Brown DR. Propofol infusion syndrome in the ICU. J Intensive Care Med. 2011;26(2):59–72.
   PubMedGoogle Scholar
• Wiesenack C, Wiesner G, Keyl C, et al. In vivo uptake and elimination of isoflurane by different membrane oxygenators during cardiopulmonary bypass. Anesthesiology. 2002 Jul;97(1):133–138.
   PubMed Web of Science ®Google Scholar
• Kaczala GW, Paulus SC, Al-Dajani N, et al. Bloodstream infections in pediatric ECLS: usefulness of daily blood culture monitoring and predictive value of biological markers. The British Columbia experience. Pediatr Surg In. 2009;25(2):169–173.
   PubMed Web of Science ®Google Scholar
• Bizzarro MJ, Conrad SA, Kaufman DA, et al. Extracorporeal life support organization task force on infections, extracorporeal membrane oxygenation. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med. 2011;12(3):277–281.
   PubMed Web of Science ®Google Scholar
• Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1–10.
   PubMed Web of Science ®Google Scholar
• Hoie EB, Swigart SA, Leuschen MP, et al. Vancomycin pharmacokinetics in infants undergoing extracorporeal membrane oxygenation. Clin Pharm. 1990;9(9):711–715.
   PubMedGoogle Scholar
• Amaker RD, DiPiro JT, Bhatia J. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 1996;40(5):1139–1142.
   PubMed Web of Science ®Google Scholar
• Buck ML. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy. 1998;18(5):1082–1086.
   PubMed Web of Science ®Google Scholar
• Mulla H, Pooboni S. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation. Br J Clin Pharmacol. 2005;60(3):265–275.
   PubMed Web of Science ®Google Scholar
• Southgate WM, DiPiro JT, Robertson AF. Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 1989;33(6):817–819.
   PubMed Web of Science ®Google Scholar
• Cohen P, Collart L, Prober CG, et al. Gentamicin pharmacokinetics in neonates undergoing extracorporeal membrane oxygenation. Pediatr Infect Dis J. 1990;9(8):562–566.
   PubMed Web of Science ®Google Scholar
• Munzenberger PJ, Massoud N. Pharmacokinetics of gentamicin in neonatal patients supported with extracorporeal membrane oxygenation. ASAIO Trans. 1991;37(1):16–18.
   PubMedGoogle Scholar
• Dodge WF, Jelliffe RW, Zwischenberger JB, et al. Population pharmacokinetic models: effect of explicit versus assumed constant serum concentration assay error patterns upon parameter values of gentamicin in infants on and off extracorporeal membrane oxygenation. Ther Drug Monit. 1994;16(6):552–559.
   PubMed Web of Science ®Google Scholar
• Ahsman MJ, Wildschut ED, Tibboel D, et al. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 2010;54(5):1734–1741.
   PubMed Web of Science ®Google Scholar
• Lindsay CA, Bawdon R, Quigley R. Clearance of ticarcillin-clavulonic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation. Pharmacotherapy. 1996;16(3):458–462.
   PubMed Web of Science ®Google Scholar
• Wildschut ED, De Hoog M, Ahsman MJ, et al. Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support. PLoS One. 2010;5(6):e10938.
   PubMed Web of Science ®Google Scholar
• Eyler RF, Klein KC, Mueller BA. The pharmacokinetics of oseltamivir and oseltamivir carboxylate in a critically ill pediatric patient receiving extracorporeal membrane oxygenation and continuous venovenous hemodialysis. J Pediatr Pharmacol Ther. 2012;17(2):173–176.
   PubMedGoogle Scholar
• Aebi C, Headrick CL, McCracken GH, et al. Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: pharmacokinetics and clearance by hemofiltration. J Pediatr. 1997;130(4):612–615.
   PubMed Web of Science ®Google Scholar
• Brüggemann RJ, Antonius T, Heijst AV, et al. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation. Ther Drug Monit. 2008;30(6):643–646.
   PubMed Web of Science ®Google Scholar
• Spriet I, Annaert P, Meersseman P, et al. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. J Antimicrob Chemother. 2009;63(4):767–770.
   PubMed Web of Science ®Google Scholar
• Ruiz S, Papy E, Da Silva D, et al. Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation. Intensive Care Med. 2009;35(1):183–184.
   PubMed Web of Science ®Google Scholar
• Koch B, Wildschut ED, De Goede AL, et al. Insufficient serum caspofungin levels in a paediatric patient on ECMO. Med Mycol Case Rep. 2012;2:23–24.
   PubMedGoogle Scholar
• van der Vorst MM, Wildschut E, Houmes RJ, et al. Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation. Crit Care. 2006;10(6):R168.
   PubMed Web of Science ®Google Scholar
• van der Vorst MM, den Hartigh J Wildschut E, et al. An exploratory study with an adaptive continuous intravenous furosemide regimen in neonates treated with extracorporeal membrane oxygenation. Crit Care. 2007;11(5):R111.
   PubMed Web of Science ®Google Scholar
• Wells TG, Fasules JW, Taylor BJ, et al. Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr. 1992;121(6):974–980.
   PubMed Web of Science ®Google Scholar
• McBride BF, White CM, Campbell M, et al. Nicardipine to control neonatal hypertension during extracorporeal membrane oxygen support. Ann Pharmacother. 2003;37:667–670.
   PubMed Web of Science ®Google Scholar
• Tobias JD, Pietsch JB, Lynch A. Nicardipine to control mean arterial pressure during extracorporeal membrane oxygenation. Pediatr Anaesth. 1996;6:57–60.
   PubMed Web of Science ®Google Scholar
• Smith T, Rosen DA, Russo P, et al. Nesiritide during extracorporeal membrane oxygenation. Pediatr Anaesth. 2005;15:152–157.
   PubMed Web of Science ®Google Scholar
• Kendrick JG, Macready JJ, Kissoon N. Amiodarone treatment of junctional ectopic tachycardia in a neonate receiving extracorporeal membrane oxygenation. Ann Pharmacother. 2006;40:1872–1875.
   PubMed Web of Science ®Google Scholar
• Robinson B, Eshaghpour E, Ewing S, et al. Hypertrophic obstructive cardiomyopathy in an infant of a diabetic mother: support by extracorporeal membrane oxygenation and treatment with beta-adrenergic blockade and increased intravenous fluid administration. Asaio J. 1998;44:845–847.
   PubMed Web of Science ®Google Scholar
• Ahsman MJ, Witjes BC, Wildschut ED, et al. Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube. Arch Dis Child Fetal Neonatal Ed. 2010;95(2):F109–14.
   PubMed Web of Science ®Google Scholar
• Wells TG, Heulitt MJ, Taylor BJ, et al. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation. J Clin Pharmacol. 1998;38(5):402–407.
   PubMed Web of Science ®Google Scholar
• Saini A, Spinella PC. Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation. Clin Lab Med. 2014;34(3):655–673.
   PubMed Web of Science ®Google Scholar
• Annich G, Adachi I. Anticoagulation for pediatric mechanical circulatory support. Pediatr Crit Care Med. 2013;14(5 Suppl 1):S37–42.
   PubMed Web of Science ®Google Scholar
• Stocker CF, Horton SB. Anticoagulation strategies and difficulties in neonatal and pediatric extracorporeal membrane oxygenation (ECMO). Perfusion. 2016;31(2):95–102.
   PubMed Web of Science ®Google Scholar
• Green TP, Isham-Schopf B, Irmiter RJ, et al. Inactivation of heparin during extracorporeal circulation in infants. Clin Pharmacol Ther. 1990;48(2):148–154.
   PubMed Web of Science ®Google Scholar
• Elliott ES, Buck ML. Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation. Ann Pharmacother. 1999;33(4):419–422.
   PubMed Web of Science ®Google Scholar
• Mulla H, Nabi F, Nichani S, et al. Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation. Br J Clin Pharmacol. 2003;55(1):23–31.
   PubMed Web of Science ®Google Scholar
• Martin GR, Chauvin L, Short BL. Effects of hydralazine on cardiac performance in infants receiving extracorporeal membrane oxygenation. J Pediatr. 1991;118:944–948.
   PubMed Web of Science ®Google Scholar
• Stone DM, Frattarelli DA, Karthikeyan S, et al. Altered prostaglandin E1 dosage during extracorporeal membrane oxygenation in a newborn with ductal-dependent congenital heart disease. Pediatr Cardiol. 2006;27(3):360–363.
   PubMed Web of Science ®Google Scholar
• Paden ML, Conrad SA, Rycus PT, et al. Extracorporeal life support organization registry report 2012. ASAIO Journal. 2013;59:202–210.
   PubMed Web of Science ®Google Scholar
• Anderson BJ, Merry AF. Data sharing for pharmacokinetic studies. Pediatr Anaesth. 2009;19(10):1005–1010.
   PubMed Web of Science ®Google Scholar
• Ince I, de Wildt SN, Tibboel D, et al. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling. Drug Discov Today. 2009;14(5–6):316–320.
   PubMed Web of Science ®Google Scholar
• Shekar K, Roberts JA, Welch S, et al. ASAP ECMO: antibiotic, sedative, and analgesic pharmacokinetics during extracorporeal membrane oxygenation: a multi-centre study to optimize drug therapy during ECMO. BMC Anesthesiol. 2012;12:29.
   PubMed Web of Science ®Google Scholar
• Laughon MM, Benjamin DK Jr, Capparelli EV, et al. Innovative clinical trial design for pediatric therapeutics. Expert Rev Clin Pharmacol. 2011;4(5):643–652.
   PubMedGoogle Scholar
• Musteata FM. Pharmacokinetic applications of microdevices and microsampling techniques. Bioanalysis. 2009;1(1):171–185.
   PubMed Web of Science ®Google Scholar
• Li W, Tse FL. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed Chromatogr. 2010;24(1):49–65.
   PubMed Web of Science ®Google Scholar
• Edelbroek PM, van der Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit. 2009;31(3):327–336.
   PubMed Web of Science ®Google Scholar
• Nováková L, Vlcková H. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal Chim Acta. 2009;656(1–2):8–35.
   PubMed Web of Science ®Google Scholar
• Millership JS. Microassay of drugs and modern measurements techniques. Paediatr Anaesth. 2011;21(3):197–205.
   PubMed Web of Science ®Google Scholar
• Anderson BJ. My child is unique; the pharmacokinetics are universal. Paediatr Anaesth. 2012;22(6):530–538.
   PubMed Web of Science ®Google Scholar
• Tod Jullien V, Pons G. Facilitation of drug evaluation in children by population methods and modeling. Clin Pharmacokinet. 2008;47(4):231–243.
   PubMed Web of Science ®Google Scholar
• Knibbe CA, Krekels EH, Danhof M. Advances in paediatric pharmacokinetics. Expert Opin Drug Metab Toxicol. 2011;7(1):1–8.
   PubMed Web of Science ®Google Scholar
• Sherwin CMT, Kiang TKL, Spigarelli MG, et al. Fundamentals of population pharmacokinetic modeling: validation methods. Clin Pharmacokinet. 2012;51(9):573–590.
   PubMed Web of Science ®Google Scholar
• Barrett JS, Della Casa Alberighi O, Läer S, et al. Physiologically based pharmacokinetic (PBPK) modeling in children. Clin Pharmacol Ther. 2012;92(1):40–49.
   PubMed Web of Science ®Google Scholar
• Holford N, Ma SC, Ploeger BA. Clinical trial simulation: a review. Clin Pharmacol Ther. 2010;88(2):166–182.
   PubMed Web of Science ®Google Scholar
• Bělohlávek J, Springer D, Mlček M, et al. Early vancomycin, amikacin and gentamicin concentrations in pulmonary artery and pulmonary tissue are not affected by VA ECMO (venoarterial extracorporeal membrane oxygenation) in a pig model of prolonged cardiac arrest. Pulm Pharmacol Ther. 2013 Dec;26(6):655–660.
   PubMed Web of Science ®Google Scholar